Related Experiment Video

Updated: May 9, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
06:31

Transuterine Fetal Tracheal Occlusion Model in Mice

Published on: February 5, 2021

Congenital diaphragmatic hernia: defect size correlates with developmental defect

1, Francesco Morini, Laura Valfrè

  • 1Bambino Gesù Children's Research Hospital, Rome, Italy.

Journal of Pediatric Surgery
|July 13, 2013
PubMed

Insights

Congenital diaphragmatic hernia (CDH) defect size correlates with severity. Larger defects indicate greater developmental abnormality, leading to higher mortality and more associated anomalies, while smaller defects are linked to better outcomes.

Area of Science:

  • Pediatric Surgery
  • Developmental Biology
  • Medical Diagnostics

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect.
  • Understanding factors predicting CDH severity is crucial for patient management.

Purpose of the Study:

  • To determine if the size of the diaphragmatic defect in CDH patients reflects the overall severity of their developmental abnormality.

Main Methods:

  • Retrospective analysis of 1350 CDH patients from the CDH Study Group registry (2007-2010).
  • Patients classified by defect size (A-D).
  • Comparison of gestational age, birth weight, associated anomalies (including cardiovascular malformations), abnormal organ systems, and hernia sac presence across defect size groups.

Main Results:

  • Mortality rates significantly increased with defect size (0.6% in A to 45.6% in D).
  • Larger defects were associated with lower gestational age, lower birth weight, increased prevalence of associated anomalies (especially cardiovascular malformations), more abnormal organ systems, and decreased hernia sac prevalence.
  • A direct correlation was observed between defect size and the severity of developmental abnormalities.

Conclusions:

  • CDH defect size is a significant predictor of mortality and developmental abnormality.
  • Defect size serves as a potential marker for the magnitude of developmental issues in CDH, influencing patient outcomes.
Abstract

Keywords:
Congenital diaphragmatic herniaDefect sizeDevelopmental defectEmbryologyPrognosis

More Related Videos

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse08:19

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on: December 16, 2022

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Related Concept Videos

Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...